文献速递妇科生殖医学

腹腔镜射频消融与子宫肌瘤剔除术后的妊娠结局比较

Pregnancy Outcomes After Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy.
PubMed 文献 · Obstet Gynecol · 2024-03-01

ULTRA研究为正在进行的多中心前瞻性队列研究,比较射频消融与肌瘤剔除术后妊娠结局。截至2023年3月,37例参与者共妊娠43次(射频消融22次、肌瘤剔除21次),两组活产率和流产率无显著差异。射频消融组1例在治疗后10周因米索前列醇治疗流产时发生子宫破裂。

要点

  • 射频消融组22次妊娠中11次活产(50.0%),9次早孕期流产(40.9%),1次30周胎死宫内,1次子宫破裂。
  • 肌瘤剔除组21次妊娠中12次活产(57.1%),9次早孕期流产(42.9%)。
  • 两组活产或流产的可能性无显著差异。

核心结论

  • 射频消融子宫肌瘤后可以实现足月妊娠和阴道分娩。
  • 然而在此中期分析中,射频消融组和肌瘤剔除组的流产率均高于该年龄段女性的预期。
  • 正在进行的ULTRA研究长期数据收集旨在进一步了解射频消融与肌瘤剔除术后的妊娠结局。

研究设计与样本

  • ULTRA(Uterine Leiomyoma Treatment With Radiofrequency Ablation)研究为正在进行的多中心前瞻性队列研究,随访至5年。
  • 研究对象为年龄大于21岁、有症状性子宫肌瘤的绝经前女性,比较射频消融与肌瘤剔除术的结局。
  • 参与者在术后每6个月接受随访,评估妊娠发生率和妊娠结局。
  • 539例女性入组ULTRA研究。

主要发现

  • 截至2023年3月,共37例参与者(首次妊娠平均年龄35.0±4.7岁)妊娠43次,其中射频消融22次、肌瘤剔除21次。
  • 所有操作后平均随访时间为2.5±1.0年,研究人群基线流产率为33.3%。
  • 射频消融组22次妊娠中9次以早孕期流产告终(40.9%,95% CI 20.3-61.5%),11次活产(50.0%,95% CI 29.1-70.9%),1次30周胎死宫内,1次在射频消融后10周因米索前列醇治疗流产时发生子宫破裂。
  • 射频消融组活产中45.5%为阴道分娩。
  • 肌瘤剔除组21次妊娠中9次以早孕期流产告终(42.9%,95% CI 21.7-64.0%),12次活产(57.1%,95% CI 36.0-78.3%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 此为中期分析。
  • 两组流产率均高于该年龄段女性的预期。
  • 正在进行的ULTRA研究长期数据收集旨在进一步了解射频消融与肌瘤剔除术后的妊娠结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare pregnancy outcomes after laparoscopic radiofrequency ablation and myomectomy. METHODS: The ULTRA (Uterine Leiomyoma Treatment With Radiofrequency Ablation) study is an ongoing multicenter prospective cohort study with longitudinal follow-up up to 5 years comparing outcomes of radiofrequency ablation with myomectomy in premenopausal women older than age 21 years with symptomatic uterine leiomyomas. Participants were queried every 6 months after surgery to assess the incidence of pregnancy and pregnancy outcomes. RESULTS: Among 539 women enrolled in ULTRA, a total of 37 participants (mean age at first pregnancy 35.0±4.7 years) conceived 43 times as of March 2023 (22 radiofrequency ablation, 21 myomectomy). The average length of follow-up time after all procedures was 2.5±1.0 years. The baseline miscarriage rate in the study population was 33.3%. In participants who underwent radiofrequency ablation, 9 of 22 pregnancies (40.9%, 95% CI, 20.3-61.5%) ended in first-trimester miscarriage, 11 resulted in live births (50.0%, 95% CI, 29.1-70.9%), one resulted fetal death at 30 weeks of gestation, and one resulted in uterine rupture during miscarriage treatment with misoprostol 10 weeks after radiofrequency ablation. Among the live births in the radiofrequency ablation group, 45.5% were by vaginal delivery. In the myomectomy group, 9 of 21 pregnancies (42.9%, 95% CI, 21.7-64.0%) ended in first-trimester miscarriage and 12 resulted in live births (57.1%, 95% CI, 36.0-78.3%). There were no significant differences in the likelihood of live birth or miscarriage between the study groups. CONCLUSION: Full-term pregnancy and vaginal delivery are achievable after radiofrequency ablation of leiomyomas. However, in this interim analysis, the miscarriage rate in both radiofrequency ablation and myomectomy groups was higher than expected for women in this age group. Long-term data collection in the ongoing ULTRA study aims to further understand pregnancy outcomes after radiofrequency ablation compared with myomectomy. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , NCT0210094.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Allen A, Schembri M, Parvataneni R, et al. Pregnancy Outcomes After Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy. Obstet Gynecol. 2024. PMID: 38422502. doi:10.1097/AOG.0000000000005548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。